Several novel biomarkers such as Neutrophil Gelatinase-Associated Lipocalin (NGAL), Kidney Injury Molecule-1 (KIM-1), and Liver-Type Fatty Acid-Binding Protein (L-FABP) have been identified to AKI diagnostic recently [11–14]. The gene discussed is LCN2; the disease is acute kidney injury.